Stem Cures Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2018
NCT04559295
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Stem Cures

Active Ingredients

Drugs in Phase 3 Trials (1)

autologous bone marrow (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 3)

Intervertebral Disc Degeneration (Phase 3)

Joint Diseases (Phase 3)

Low Back Pain (Phase 3)

Radiculopathy (Phase 3)

Spinal Stenosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1